Answers are grounded in this paper and cite their sources.
Observational findings indicate increased mortality and hospital stay in neurological patients, suggesting management changes are needed.
In a period in which access to Ig may have been limited, neurological patients, but not patients with immunodeficiencies, show an increase in LoS and mortality, as well as an increased TPE. These results suggest that modifying the management strategy of patients with neurological disorders requiring Ig due to restrictive conditions could have negatively impacted their clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Querol et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: